Dr. Mohamed Shafiu, MD

Dr. Shafiu practices at Renal Associates, P.A. in San Antonio, Texas.

Dr. Shafiu's NPI, 1174685648, was assigned on December 14, 2006. Dr. Shafiu graduated from Nishtar Medical College in 2000. Dr. Shafiu holds Texas license N2789.

Dr. Shafiu's primary practice is Renal Associates, P.A., at 5620 Lone Star Pkwy, San Antonio, TX 78253 in Bexar County. The practice phone is (210) 614-1231.

Dr. Shafiu's primary practice is Renal Associates, P.A. in San Antonio, Texas. Dr. Shafiu is also affiliated with Methodist Hospital. The medical group on file is Renal Associates. Dmand AI also links Dr. Shafiu to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shafiu practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Shafiu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Shafiu is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Shafiu's licenses on file in 2 states: Texas and Florida.

Dmand AI lists chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Shafiu treats.

CMS data shows 2,785 Medicare services from Dr. Shafiu across 17 procedure codes in 2024, for 403 Medicare patients. Medicare paid $212,082 for them.

CMS counts 403 Medicare patients who saw Dr. Shafiu in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 3.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shafiu's median patient age at 70, with 51% women.

In 2024, Dr. Shafiu wrote 3,694 Medicare Part D claims for 380 patients. 73% of them were for generic drugs. CMS names the drug for 3,252 of them, across 62 drugs with 11 or more claims each, at $1,112,135 in total drug cost. In 2023, CMS named 2,383 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shafiu for performance year 2024, reported as part of a group. Dr. Shafiu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shafiu as offering telehealth.

Dmand AI links 6 papers to Dr. Shafiu, published from 2009 to 2013. The most frequent topics are Uric Acid, Metabolic Syndrome and Diabetes Mellitus, Type 2. Dr. Shafiu's most frequent co-authors are Daniel Feig, MD, PhD, Richard J. Johnson, MD and Mark S. Segal, MD.

CMS Open Payments shows 441 general payments to Dr. Shafiu from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,875.

Dmand AI lists 1 award for Dr. Shafiu, most recently CMS Stage 1 EHR in 2012.

Dr. Shafiu graduated from Nishtar Medical College in 2000.

Dr. Shafiu is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.